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branes with the help of mitochondrial import machineries (for Abstract The orientation of a mitochondrial presequence 
peptide, associated with anionic lipid-containing model mem- reviews, see [1,2]). Translocation of the presequence across the 
branes, was investigated. The peptide inserts with its N-terminal inner mitochondrial membrane requires a membrane potential 
a-helical part into cardiolipin (CL) monolayers o that the N- (A~) across that membrane [3,4]. 
terminal 14 residues are protected from proteinase K. In Although the amount of information about the import pro- 
phosphatidylglycerol (PG) monolayers the inserted peptide was cess and components involved is still growing, the molecular 
fully accessible to the protease. A consequence of the different mechanism of the protein translocation process is largely un- 
orientations of the peptide was that membrane potential- known. This applies in particular to the molecular interactions 
dependent protection from trypsin was much faster for the the presequence is involved in. The presequence is assumed to 
peptide bound to PG-eontaining vesicles compared to CL- interact with different proteinaceous components of the im- 
containing membranes, suggesting that in the mitochondrial 
protein import process other components of the import apparatus port apparatus, as well as with membrane lipids (cf. [5,6]). Of 
are involved in the efficient potential-driven translocation of special interest is cardiolipin (CL), a phospholipid with a un- 
presequences across the inner mitochondrial membrane, ique chemical structure, which in the eukaryotic ell is only 
synthesized [7] and found in mitochondria [8,9]. Several ob- 
Key words." Mitochondrial presequence; Peptide topology; servations suggest that presequences have a special interaction 
Monolayer insertion; Amino acid sequence analysis; with this lipid. Different mitochondrial proteins bind specifi- 
Membrane potential cally to CL-containing liposomes [10,11]. CL can unfold pre- 
cursor proteins [12], and synthetic presequence peptides can 
induce intermembrane contacts which depend on the presence 
1. Introduction of CL in the membranes [13-15]. Recently, a 2D 1H-NMR 
study revealed that CL can modulate the secondary structure 
Proteins, synthesized in the cytosol as precursors, and des- of the peptide, corresponding to the presequence of cyto- 
tined for the mitochondria, generally carry an amino terminal chrome oxidase subunit IV from yeast (p25) [16]. In that 
extra sequence, the presequence. This presequence is required study, it was observed that, associated with dodecylphospho- 
for the import of these proteins into mitochondria nd is choline micelles, there was a-helix formation in p25 from the 
proteolytically removed once it has reached the mitochondrial N- to the C-terminus, with a break at the proline residue at 
matrix. The import process involves binding to the mitochon- position 13. Upon introduction of CL, an increased stability 
drial outer surface, and translocation across one or two mere- of the a-helix was observed around proline 13 and in the C- 
terminal half. This suggests that the presequence-CL interac- 
tion results in a specific mode of insertion of the peptide in 
CL-containing membranes. This question is addressed in this 
*Corresponding author. Fax: (31) (30) 2539171. study. It is demonstrated that in the presence of CL the N- 
E-mail: cble_bm@chem.ruu.nl terminal ct-helical half is deeply embedded in the hydrophobic 
core of CL-containing membranes. The consequences of this 
**Present address. Institute of Biochemistry, Biological Research CL-specific orientation of p25 for action of a transmembrane 
Center, Hungarian Academy of Sciences, H-6701 Szeged, 
P.O. Box 521, Hungary. potential on the peptide are also investigated. 
Abbreviations." ATR, attenuated total reflection; CL, cardiolipin; 2. Materials and methods 
DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; DOPG, 1,2-dio- 
leoyl-sn-glycero-3-phosphoglycerol; egg PC, phosphatidylcholine from 
egg yolk; EDTA, (ethylenedinitrilo)tetraacetic acid; FTIR, Fourier 2.1. Materials 
transform infrared; HEPES, N-(2-hydroxyethyl)piperazine-N'-2-etha- Cardiolipin from bovine heart, 1,2-dioleoyl-sn-glycero-3-phospho- 
nesulfonic acid; ~i, initial surface pressure; A~, surface pressure choline (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoglycerol (DOPG), 
increase; A~, membrane potential; LUVs, large unilamellar vesicles; 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG), and phos- 
p25, peptide corresponding tothe presequence of cytochrome oxidase phatidylcholine from egg yolk (egg PC) were obtained from Avanti 
subunit IV; p25NBD, p25 labeled with 7-nitro-2,1,3-benzoxadiazol-4- Polar Lipids, Inc. (Birmingham, AL, USA). 
yl; PK, proteinase K; POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3- The peptide corresponding to the presequence of yeast cytochrome 
phosphoglycerol oxidase subunit IV (p25, H3N+-Metl-Leu-Ser-Leu-ArgS-Gln-Ser-Ile - 
0014-5793/96l$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
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Arg-Phel°-Phe-Lys-Pro-Ala-ThrlS-Arg-Thr-Leu-Cys-Ser2°-Ser-Arg - 2.6. Fluorescence spectroscopy 
Tyr-Leu-Leu25-CONH2) was prepared by Dr. A.I.P.M. de Kroon as Fluorescence measurements were performed at 20°C on an SLM- 
described previously [17]. The peptide was purified and identified as Aminco SPF-500C fluorometer, using an excitation wavelength of 485 
described previously [14]. P25 was S-alkylated with N,N'-dimethyl-N- nm and an emission wavelength of 540 nm (5 nm band passes). 
(iodoacetyl)-N'- (7-nitro-2,1,3-benzoxadiazol-4-yl)-ethylene-diamide 
(IANBD amide) (Molecular Probes, Eugene, OR, USA) at Cys 19 2.6.1. 1(1 quenching 
(p25NBD) and purified by M. Maduke as described [18]. These experiments were performed under conditions that all peptide 
p25 peptide solutions were prepared at concentrations between 0.2 was bound to the LUVs consisting of CL/DOPC or DOPG/DOPC 
and 1 mM in water and stored at -20°C. p25NBD was dissolved at a (both 2/8, molar ratio, based on phosphorus concentrations). 
concentration of 0.2 mM in 50% ethanol and stored at -20°C. p25NBD binding to the LUVs was determined as described [18]. 
For measuring the fluorescence quenching of free p25NBD in buffer 
2.2. Monolayer experiments (50 mM K2SO4, 10 mM HEPES (pH 7.0), 1 mM EDTA), a 100 nM 
All monolayer experiments were carried out in Teflon dishes at peptide concentration was used. Quenching in the presence of LUVs 
22°C as described by Trrrk et al. [15]. The experiments using p25 was performed with 20 nM p25NBD and 200 p.M LUVs (phosphorus 
were performed in a 6 ml dish with a surface area of 8.8 cm 2. Mono- concentration). To 1 ml of these solutions, KI was added in increasing 
layers of DOPG or CL were spread on a subphase of 150 mM amounts from a 4 M stock solution containing 1 mM Na~S203 to 
NazSO4, 20 mM HEPES (pH 7.0) and 2 mM EDTA from prevent 12 and 13-formation, and the fluorescence intensity was read 
CHC13 :CH3OH (4:1, v/v) to give the desired initial surface pressure, at 540 nm. The values were corrected for dilution and vesicle scatter- 
Peptide and proteinase K (PK, Boehringer Mannheim GmbH, Man- ing. Data were analyzed according to the Stern-Volmer equation for 
nheim, Germany) were added through a hole in the Teflon chamber collisional quenching [23]: F0/F=-I+ Ksv.[Kl], where Ksv is the Stern- 
connected to the stirred subphase. Volmer quenching constant, and F0 and F are the (corrected) fluor- 
In experiments aimed at identifying the protected presequence p p- escence intensities in the absence and presence of quencher. To correct 
tide fragment, the subphase was washed by injecting and ejecting for a possible decrease in binding of p25NBD upon increasing the salt 
buffer solution and, subsequently, water, at opposite sides of the concentration, F0 was determined in a similar titration experiment 
dish at a rate of 13 ml/min. After washing of the subphase, mono- using KC1 instead of KI. 
layers were collected in a vial as described by Rietsch et al. [19] and 
lyophilized for sequence analysis. 2.6.2. Protease protection 
Time- and potential-dependent protection of vesicle-bound 
2.3. Sequence analysis p25NBD from added trypsin was measured essentially as described 
Samples were redissolved in 50 ktl H20, and subsequently analyzed [18]. These experiments were also performed under conditions that all 
for N-terminal amino acid sequence of the peptide (fragments) by the peptide was bound to the vesicles. LUVs (40 mM) were made in buffer 
Sequentiecentrum (Utrecht, The Netherlands). The analysis was car- containing 50 mM K2SO4, 10 mM HEPES (pH 7.0), and 1 mM 
ried out on an Applied Biosystems Protein Sequencing system (model EDTA, and consisted of CL/egg PC or POPG/egg PC (both 2/8 molar 
476A), using the Edman degradation procedure, followed by 'on-line' ratio, based on phosphorus). Valinomycin (Boehringer Mannheim; 9
microbore HPLC identification of the phenylthiohydantoin deriva- ktM final concentration) was added (from a 1 mg/ml stock solution in 
rives of the amino acids. The samples were analyzed for 20 subsequent ethanol) directly to this lipid solution. LUVs were diluted 100-fold in 
steps. For comparison of the repetitive yield, p25 was also analyzed. 1 ml buffer, containing 50 mM Na2SO4, 10 mM HEPES (pH 7.0), and 
1 mM EDTA, to generate a membrane potential. For control experi- 
2.4. Vesicle preparation ments, LUVs were diluted in K2SO4-containing buffer, so that no A~/ 
Dry lipid films were hydrated by manual shaking or vortexing in could be generated. To this solution, at t=0, p25NBD was added (20 
buffer consisting of 50 mM K2SO4, 10 mM HEPES (pH 7.0) and 1 nM final concentration). At different time points, trypsin (Sigma Che- 
mM EDTA (fluorescence spectroscopy) or in water (infrared (IR) mical Co., St. Louis, MO, USA; 50 txg) was added, and the percen- 
spectroscopy), and subsequently frozen and thawed 10 times. Large tage protected peptide was determined from the fraction of the initial 
unilamellar vesicles (LUVs) were prepared by the extrusion technique fluorescence of p25NBD bound to the LUVs remaining after trypsin 
[20] using 100 nm polycarbonate filters, treatment. 
2.5. IR spectroscopy 2.7. Other methods 
Samples were prepared by addition of 18.4 nmol p25, preincubated p25 peptide concentrations were determined using a micro-BCA 
with 50 mM dithiothreitol for 30 min at room temperature, to 0.184 protein assay (Pierce, Rockford, IL, USA), using bovine serum albu- 
~tmol LUVs (phosphorus) consisting of either CL/DOPC (2/8, w/w) or min as a standard, p25NBD concentration was determined by amino 
DOPG/DOPC (2/8, w/w), in the presence of 50 mM dithiothreitol, acid analysis. Phosphorus concentrations were determined according 
The lipid/peptide mixture was incubated for 30 min at 37°C, after to Rouser et al. [24]. CL concentrations are always given as phos- 
which LUVs with bound p25 were isolated by sucrose gradient cen- phorus concentrations. 
trifugation, as described in Vandenbussche et al. [21]. The LUVs/pep- 
tide complex was washed 3 times by centrifugation (35 min, 3. Results 
300 000 × g), dried on a clean Ge internal reflection element by slow 
evaporation at room temperature under a N2 stream, and rehydrated 
under a N2/D~O flow for 2 h. 3.1. The N-terminal half of the presequence peptide inserts 
Fourier transform attenuated total reflection (FT-ATR) infrared specifically in CL monolayers 
spectra were recorded at room temperature on a Perkin-Elmer In the present study, PG was chosen for comparison with 
1720X FTIR spectrophotometer, quipped with a mercury-cad- 
mium-telluride detector. Spectra were recorded at a nominal resolu- CL. PG can be considered to be a representative for other 
tion of 4 cm -1 and encoded every 1 cm -1. anionic phospholipids, like phosphatidylserine and phosphati-  
Germanium crystals (50×20×2 mm, Harrick EJ 2121) were dylinositol, which show a less specific interaction with prese- 
cleaned by washing with distilled water, methanol and chloroform, quences [10,13], and moreover, PG and CL are structurally 
and subsequently placed for 5 min in a Plasma Cleaner PDC-23G 
(Harrick Scientific, Ossining, NY, USA). The crystals were placed related. To get insight into the differences in topology of the 
under an aperture angle of 45 °, yielding 25 internal reflections. A inserted presequence peptide in either CL- or PG-containing 
clean germanium plate was used for simultaneous background correc- membranes,  monolayer experiments were done, in which pro- 
tion. Perkin-Elmer gold wire grid polarizers were placed in front of teinase K was used as a tool to monitor  the accessibility of the 
the sample and reference holder, making it possible to record spectra inserted peptide. This approach has the advantage that the 
at 0 ° and 90 ° polarization of the incident light beam. The determina- 
tion of the secondary structure and of the orientation of the a-helix interactions and their consequences for lipid packing can be 
with respect to a normal to the Ge crystal was performed as described continuously recorded. Typical experiments, using either a CL 
[22]. monolayer (A) or a PG monolayer (B), are shown in Fig. 1. 
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. , , PK-protected part was identified. An experiment was done 
50 [ ]  in which PK was added to the subphase of a CL monolayer 
, with p25 inserted into the monolayer (as in Fig. 1A). After the 
I 
surface pressure had stabilized, the subphase was washed with 
A~pK buffer, and subsequently with water to remove PK, digested 
~" 40 -~ . . p25 and salts. Next, the monolayer with the protected peptide 
Z was collected, lyophilized and dissolved in a small volume of 
E,E ~ water, and the sample was analyzed by N-terminal peptide 
UJ 30  sequence analysis. The result of the HPLC analysis of the first 
t r  cycle is shown in Fig. 2. By far the most abundant residue 
:3 present in this analysis was a methionine, in p25 only present t/) 
as the first amino acid. With an estimate of the amount of 
LU [ [ inserted p25 in the monolayer, the yield of this first cycle of r r  
50 I [ ]  the amino acid sequence analysis is approximately 50%. The 
LU ~ same yield was obtained when a known amount of intact p25 
O t ' ~  ~ was analyzed by N-terminal sequence analysis. This demon- 
14, ~ A~I  ~ ~-- strates that the majority of the amount of peptide which was tr 4o  ATI;pK responsible for the induced surface pressure increase has an 
intact N-terminus, already indicating that a part of each pep- 
tide was digested by PK and not part of the total amount of 
30 inserted peptide. The analyses of the following 14 cycles each 
resulted in the expected subsequent residue of p25 being the 
main amino acid found by HPLC analysis (except for the 
I ' serine residues, which are underestimated in this procedure; 
0 20  40 data not shown). For cycle 15, no distinct peak of threonine 
TIME (min.) was detectable, confirming that part of p25 had indeed been 
removed by the proteinase. These results demonstrate hat the 
Fig. 1, Proteinase K digestion of p25, inserted into a monolayer of N-terminal 14 residues of p25 were protected against PK 
CL (A) or DOPG (B). p25 was injected to a subphase concentration treatment of p25 inserted into a CL monolayer. of 1.5 ~tM underneath a lipid monolayer at t=0, resulting in a sur- 
face pressure increase (An). At the points indicated with the arrows, 
PK (30 ~tg/ml) was added to the subphase, resulting in a decrease in 3.2. Lipid specificity of A~-driven movement of  the presequence 
surface pressure, defined at 30 rain after PK addition as ArCpK. peptide 
In an earlier study, Maduke and Roise [18] concluded that 
A monolayer was spread to an initial surface pressure (hi) of upon application of a potential across the membrane of PG/ 
30-31 mN/m, and, at t=O, p25 was injected underneath it, PC LUVs, p25NBD could be translocated into the lumen of 
resulting in a large surface pressure increase (An), similar for the vesicles. Because of the observed ifferent mode of inser- 
both lipid systems, indicating the insertion of the presequence, tion of p25 with either PG- or CL-containing membranes, the 
After 10 min, PK was added to the subphase, resulting in a consequences for the A~-driven translocation of p25NBD 
fast surface pressure decrease, which in the case of the PG across the different bilayers were investigated. Therefore, the 
monolayer continues until after approximately 30 min the 
surface pressure has reached the ni value of the lipid mono- 
M IDPTUI I 
layer, the surface pressure initially decreases rapidly, but then 
the decrease slows down or even stops, and a certain part of 8.oo 
the p25-induced Arc remains (zXg--A~pK). Addition of an extra 
amount of PK did not result in a further decrease of the sur- ~. 6.oo 
face pressure, demonstrating that the amount of protease was 
not the limiting factor. Mastoparan, which like p25 is a posi- ~ 4.00 r 
tively charged amphipathic (x-helical peptide [25], did not dis- oq ~ ~/ t~ I _ / ,  s Q ~ A ~ , L -~ 
play such CL-specific protection under similar conditions zoo  
(data not shown), demonstrating the presequence specificity A 
of this observation. These results indicate that in CL, and k~J~, j~& ~/ 
not in PG monolayers, part of the presequence peptide is 0.oo  
I I I I 
deeply inserted and cannot be digested by PK. This part 4.0 8.0 12.0 16.0 20.0 
can either be a part of each peptide molecule, so that approxi- TIME (min.) 
mately half of the peptide is inserted in a way that it cannot Fig. 2. HPLC analysis of the first cycle of the amino acid sequen- 
be reached by the protease, while the other half of the mole- cing of a collected monolayer sample. To the subphase of a CL 
cule is readily digested. Or it could be that half of the total monolayer with p25 inserted, PK was added (see Fig. 1A) and, after 
amount of peptide molecules is localized in such a way that it 30 rain, the subphase was washed with buffer and subsequently 
water. After this, the monolayer was collected, lyophilized, and sub- 
is not digested by PK, while there is a second population of jected to amino acid analysis. The amino acids are indicated by 
molecules that is inserted, but accessible to the protease, their one-letter abbreviations. DMPTU, DPTU and DPU are by- 
In order to distinguish between the two possibilities, the products of the Edman degradation chemistry. 
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100" N-terminal a-helix parallel to the acyl chains. This result was 
reproduced in our experimental system and compared with 
the peptide upon interaction with PG/PC membranes, for 
80 which no preferred orientation of the helical content of the 
peptide was found (not shown). Thirdly, despite the fact that 
upon binding both to CL- and to PG-containing LUVs, the 
~" 60 part of peptide containing the NBD, attached to cysteine 19, 
.~ could be readily digested by protease, the precise topology of 
" ~ 40" the C-terminal half of the peptide appeared to be different in 
the two systems. Iodine quenching experiments revealed that 
e~ ~ the NBD was inserted more deeply in the case of PG/PC 
20" LUVs (Ksv =1.0 M -1) than CL/PC LUVs (Ksv =1.7 M- l ;  
data not shown), which is in good agreement with the recently 
described results on p25, spin-labeled at cysteine 19, using elec- 
01 • . , tron spin resonance spectroscopy [27]. Fourthly, the different 
0 5 10 15 mode of insertion into the two lipid systems is supported by 
the molecular areas reported for the p25 in CL and PG mono- 
Time (min.) layers. This area was determined to be 330 ~2 [15] and 530 ~2 
Fig. 3. Time-dependent protection of 20 nM p25NBD against added [28] for CL and PG, respectively. The difference can now be 
trypsin (50 ktg). In the presence of 400 ~tM PG/PC (2/8 molar ratio, explained by a different orientation of the N-terminal half of 
triangles) or CL/PC (2/8 phosphate molar ratio, circles) LUVs, ex- the peptide. In CL monolayers it inserts with the helix axis 
periencing a membrane potential. A membrane potential (negative parallel to the acyl chains, which results in a protected loca- 
inside) was generated by diluting LUVs, made in K+-containing 
buffer, 100-fold in Na+-containing buffer, in the presence of valino- lization for the N-terminal 14 residues and a small area for 
mycin. The percentage protection is calculated as the fraction of that part of the peptide, while the C-terminal half is oriented 
fluorescence r maining after trypsin treatment, corrected for vesicle at the lipid-water interface, making the major contribution to 
scattering and for NBD fluoresence of p25NBD in the absence of the molecular area. In PG monolayers the amphipathic helix 
vesicles, but in the presence of trypsin. The error bars indicate the 
standard eviations (n=4). most probably lies parallel to the lipid-water interface, as 
proposed by Tamm [28], resulting in the larger molecular 
area. The proposed topology of the peptide at a PG-contain- 
time- and A~-dependent protection of p25NBD from diges- ing membrane surface is in agreement with the fact that the 
tion by externally added trypsin was investigated for the two full length of the presequence was found to be accessible to 
lipid systems. These experiments were done under conditions the protease when inserted in a PG monolayer (this study) 
that all p25NBD was bound to the LUVs. The results, shown and with the recently determined topology of p25 bound to 
in Fig. 3, confirm the earlier observation [18] that, in the PG/PC (1/9 molar ratio)bilayers using electron paramagnetic 
presence of PG/PC LUVs, protection of p25NBD is fast, resonance spectroscopy [29]. 
such that 80% of the p25NBD present is protected from tryp- Taken together, these findings suggest a different behavior 
sin digestion in 10 min. However, in the CL-containing sys- for the N- and the C-terminal halves of the presequence pep- 
tem, time-dependent protection of that part of the peptide tide in interaction with CL-containing membranes. In a pre- 
containing the NBD moiety is much slower. If PK was used vious study, the effect of CL on the secondary structure of p25 
instead of trypsin the results were identical. In all cases, pro- was investigated by 2D tH-NMR [16]. It was found that in 
tection was A~-dependent, because in the absence of A~ the presence of CL there was an increased helical stability in 
p25NBD was sensitive to digestion by the protease (< 10% the region around proline 1~ and in the C-terminal half. Based 
protection). This suggests that the part of the peptide contain- on these findings, a structure of p25 was proposed in which 
ing the NBD moiety is surface-localized in the case of both the helix is bent due to specific interactions with CL. The data 
PG- and CL-containing LUVs. It can thus be concluded that of the present study are consistent with such a structure. The 
the A~-driven inward movement of the C-terminus of the amino terminal a-helical part inserts deeply into the hydro- 
presequence does occur in the case of CL-containing vesicles, phobic core, oriented with its helix axis parallel to the lipid 
but is very much slower than in the case of PG-containing acyl chains. The C-terminal half is superfacially localized at 
vesicles, the membrane surface, which might be involved in intermem- 
brane contact formation, as also suggested by Snel et al. [27]. 
4. Discussion This presequence peptide-induced process was found to re- 
quire the presence of CL in the membranes [13,15], further 
The results of this study demonstrate a different opology of demonstrating the involvement of specific interactions be- 
a mitochondrial presequence peptide inserted into CL-con- tween the peptide and CL. A molecular model of the topology 
taining membranes, compared to PG-containing membranes, of peptide in the two different systems has been described by 
This was concluded from a number of experiments. Firstly, Leenhouts et al. [30]. 
the monolayer experiments demonstrate hat only in the case The unique mitochondrial localization of CL and the ob- 
of CL was a defined fragment of the peptide protected from served specific interactions between CL and mitochondrial 
protease digestion. Sequence analysis identified residues 1-14 presequences suggest a role of this lipid in the mitochondrial 
as being protected in the monolayer. Secondly, from previous protein import pathway. Because of the localization of CL 
FTIR results [26] it can be concluded that the interaction of primarily in the inner mitochondrial membrane, it would be 
the presequence peptide with CL leads to an insertion of the likely that CL is involved in the specific insertion of the pre- 
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